Emotion recognition in schizotypy by Brown, Laura
Louisiana State University
LSU Digital Commons
LSU Master's Theses Graduate School
2010
Emotion recognition in schizotypy
Laura Brown
Louisiana State University and Agricultural and Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_theses
Part of the Psychology Commons
This Thesis is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU
Master's Theses by an authorized graduate school editor of LSU Digital Commons. For more information, please contact gradetd@lsu.edu.
Recommended Citation
Brown, Laura, "Emotion recognition in schizotypy" (2010). LSU Master's Theses. 4022.
https://digitalcommons.lsu.edu/gradschool_theses/4022



















Submitted to the Graduate Faculty of the  
Louisiana State University and  
Agricultural and Mechanical College 
In partial fulfillment of the  
Requirements for the degree of  























Table of Contents 
 
List of Tables. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
iv 
Abstract. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
v 
Introduction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
1 
Review of the Literature. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
 Schizophrenia. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
  Symptoms. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  2 
  Neurocognition. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4 
  Social Cognition. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  5 
  Emotion Recognition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  6 
            Schizotypy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  11 
  Symptoms. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  12 
  Measurement of Schizotypy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  13 
  Neurocognition. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  15 
  Social Cognition. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  16 
  Emotion Recognition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 
17 
Purpose. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  21 
            Research Questions and Hypotheses. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 
21 
Method. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  23 
 Participants. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  23 
 Measures. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  24 
  Schizotypal Personality Questionnaire. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  24 
  Lehman’s Quality of Life Brief Interview . . . . . . . . . . . . . . . . . . . . . . . . . . .  25 
  Penn Emotion Recognition Test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  25 
  Repeatable Battery for the Assessment of Neuropsychological Status. . . . .  
 
26 
Analyses. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  . . . . . .  
 
27 
Results. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   28 
 Group Comparisons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  28 
                        Demographics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 
  Clinical Variables. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  29 
  Neurocognition. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  29 
  Emotion Recognition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  29 
 Within Schizotypy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
  
30 
Discussion. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
34 
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  39 
 iii 
 
Appendix A: Schizotypal Personality Questionnaire . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
  
52 
Appendix B: Lehman’s Quality of Life Brief Interview . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
55 
Appendix C: Example of PERT Stimuli. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
60 
Appendix D: Semantic Affective Moniker. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
 
61 




















List of Tables 
1. Means and Standard Deviations for Demographic and Clinical Variables for Schizotypy 




2. Means and Standard Deviations for RBANS Index Scores in the Schizotypy and 




3. Means and Standard Deviations for PERT Scores in the Schizotypy and Control Groups 
 
30 
4. Pearson’s Correlations Between RBANS Index Scores and PERT Accuracy. . . . . . . . . .  
 
31 
5. Spearman’s Correlations Between SPQ Factors and PERT Variables. . . . . . . . . . . .  
 
32 



















 Deficits in social cognition are repeatedly found in individuals with 
schizophrenia. Facial emotion recognition is a major aspect of social cognition in which 
individuals with schizophrenia show consistent deficits. However, many questions about 
these deficits remain unanswered including whether they occur in individuals with 
schizotypy—those at high risk for the disorder that do not manifest full pathology.  
Examining emotion recognition in schizotypy eliminates many of the confounds 
associated with schizophrenia research such as medication effects, chronic 
institutionalization, and generalized cognitive deficits, and allows for the examination of 
whether emotion recognition deficits reflect vulnerability to schizophrenia. Prior research 
in this population has yielded mixed findings and is subject to a number of limitations 
including measurement of only a subset of schizotypy symptoms and use of non-
validated or less sensitive emotion recognition measures. The current study examined 
emotion recognition in control and psychometrically-identified schizotypic individuals, 
employing a well-validated emotion recognition task that allowed for the examination of 
accuracy and bias scores. Of interest was whether individuals with schizotypy would 
show deficits when labeling emotional faces, whether they would exhibit biases when 
rating the emotional valence of faces, and how these variables relate to neurocognitive 
abilities, symptoms, and quality of life. Results indicate that individuals with schizotypy 
were significantly less accurate than controls when labeling facial emotions; however, 
they did not show generalized impairment on neurocognitive measures. Within the 
schizotypy sample, both disorganization symptoms and lower quality of life were 
associated with a bias toward perceiving facial expressions as more negative. Results 
 vi 
support prior studies suggesting that poor emotion recognition is associated with 
vulnerability to psychosis even in the absence of neurocognitive impairment. Results also 
offer evidence of social cognitive biases in schizotypy, and suggest that these biases may 









 Schizophrenia is a devastating disorder distinguished not only by a variety of 
bizarre behaviors but also deficits in neurocognition, social cognition, and overall 
functioning. First, I give a brief overview of schizophrenia symptomology and associated 
cognitive deficiencies. Next, I consider research on facial emotion recognition, an 
important domain of social cognition. Facial emotion recognition is generally impaired in 
individuals with schizophrenia, however it is unclear whether this impairment is better 
understood as a reflection of generalized neurocognitive deficits or a specific impairment 
in emotion recognition ability. However, facial emotion is specifically related to social 
behavior and overall functioning. I then turn to examining these issues in individuals with 
schizotypy, or those with the purported genetic liability for schizophrenia that do not 













Review of the Literature 
Schizophrenia 
 Schizophrenia is a disorder characterized by impaired reality testing, odd 
behaviors, and substantial social and occupational dysfunction. It is estimated that about 
0.4 percent of the United States population is affected (Wu, Shi, Birnbaum, Hudson, & 
Kessler, 2006). In 2001, the World Health Organization named schizophrenia among the 
top ten causes of healthy life lost to disability (World Health Organization, 2001).  
Schizophrenia has been recognized by physicians and researchers for many years. It was 
once termed demence praecoce or “early dementia” (Morel, 1890) as physicians thought 
it entailed progressive deterioration. Emil Kraepelin was instrumental in characterizing 
symptoms and outcome (1919; 1971). The disorder was finally named schizophrenia 
meaning “split mind” by Eugen Bleuler in 1911, focusing on what he termed the splitting 
of psychic functions (1911; 1950).   
Symptoms 
 Individuals with a diagnosis of schizophrenia may display extremely variable 
symptoms, sometimes experiencing acute psychosis, sometimes predominant symptoms 
of amotivation and flat affect, and often severe cognitive and emotional deficits 
(Andreasen, 1997). Although many different symptoms are manifest in an individual 
simultaneously, not all patients display the same symptoms. Further complicating the 
issue, none of the symptoms are specific to schizophrenia (American Psychiatric 
Association, 2000), and efforts to determine with disorder-specific criteria have been 
largely unsuccessful (e.g. first rank symptoms, Schneider, 1959; Nordgaard, Arnfred, 
Handest, & Parnas, 2008). Patients also show a variable course, with some displaying 
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intermittent psychotic episodes followed by  periods of clinical stability and others 
exhibiting a chronic course characterized by lack of motivation and emotional expression 
with transient delusions and hallucinations (Gerbaldo, Cassady, & Helisch, 1995).   
 There have been two broad strategies for reducing heterogeneity of symptoms.  
The first involves the notion that schizophrenia is not a single disorder but a collection of 
disorders with separate etiologies lumped together under one category (Crow, 1980). 
Absent evidence of separate etiologies, however, and considering that separate 
syndromes can occur simultaneously in the same individual, the most parsimonious 
solution is that schizophrenia represents a single disorder (Crow, 1985). A number of 
taxonomies have been put forward delineating distinct subtypes of the illness.  For 
example, very early in the history of schizophrenia, distinctions were made between 
“process” and “reactive” types (Kantor, Wallner, & Winder, 1953). Crow (1985) also 
noted two types of schizophrenia: Type I and Type II. The DSM-IV-TR attempts to 
address the issue of heterogeneity by defining particular subtypes including paranoid, 
disorganized, residual, and undifferentiated (APA, 2000). Some problems with the DSM-
IV-TR subtypes are that the subtypes diagnoses are not particularly reliable or stable 
(Blashfield, 1973; Gruenberg, Kendler, & Tsuang, 1985), and many patients seem to fall 
into the “undifferentiated” category (Kendler, 1985).   
 A second strategy for understanding heterogeneity is using a statistical method.  
Much research suggests that particular symptoms cluster together. The most accepted 
model distinguishes three symptoms clusters and comes from a factor analysis done by 
Liddle (1987) that found positive, negative, and disorganization factors. More recent 
research has supported this factor structure (Malla, Norman, Williamson, & Cortese, 
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1993; Andreasen, Arndt, Alliger, Miller, & Flaum, 1995). Positive symptoms include 
delusions and hallucinations and reflect an exaggeration of behaviors present in non-
disordered individuals. Negative symptoms reflect the absence of behaviors normally 
present in non-disordered individuals. They include flat or blunted affect, avolition, 
anhedonia, and alogia. Disorganization symptoms include disorganized speech, 
disorganized or bizarre behaviors, and inappropriate affect. Positive symptoms are the 
least stable (Fenton & McGlashan, 1991), respond best to medications (Tandon et al., 
2008), and are not a good indicator of prognosis (Strauss, Carpenter, & Bartko, 1975; 
Addington & Addington, 1991). Negative symptoms are the most stable and generally do 
not respond well to treatment (Arndt et al., 1995), with the exception of those secondary 
negative symptoms that occur in response to positive or other mood symptoms 
(Carpenter, Heinrichs, & Alphs, 1985; Goldberg, 1985; Arango, Buchanan, Kirkpatrick, 
& Carpenter, 2004). Less is known about how disorganization symptoms related to 
functioning and other symptoms. They seem to be correlated with executive functioning, 
attention (Moritz et al., 2001; Kerns & Berenbaum, 2002), and social information 
processing deficits (Brune, 2003; Shean, Murphy, & Meyer, 2005).   
Neurocognition 
 Neurocognitive deficits were noted early in the history of schizophrenia and seem 
to be a hallmark of the disorder. Bleuler (1950) and Kraepelin (1899) wrote about deficits 
in attention, perception, and cognition, and other researchers have characterized 
schizophrenia by a generalized deficit in any task requiring a “voluntary response” 
(Chapman & Chapman, 1978). Particular areas of deficiency in schizophrenia include 
processing speed, attention/vigilance, working memory, verbal learning and memory, 
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reasoning and problem solving, and verbal comprehension (Neuchterlein, Barch, Gold, 
Goldberg, Green, & Heaton, 2004). In 1996, a seminal review article highlighted the 
importance of basic neurocognitive deficits in schizophrenia (Green, 1996). This review 
revealed, first, that negative symptoms predict overall functional outcome, but positive 
symptoms do not. Neurocognitive deficits, however, were the best single predictor or 
functional outcome in individuals with schizophrenia. Specifically, there may be 
neurocognitive “rate limiting factors” that prevent patients from acquiring certain 
necessary skills. The effect size is small (d = .20 to .40) in cross-sectional studies (Green, 
Kern, Braff, & Mintz, 2000) and much lower in longitudinal studies (Milev, Ho, Arndt, & 
Andreasen, 2005) but is stable (Addington & Addington, 2000). Further research has 
shown that the pathway from neurocognitive deficits to overall functioning may be best 
understood as medicated by social cognition as discussed below.   
Social Cognition 
Social cognition is defined as the way people think about themselves and others 
(Penn, Sanna & Roberts, 2008) and includes social perception, interpretation, and 
processing (Penn, Corrigan, Bentall, Racenstein, & Newman, 1997). One theory 
emerging from the social psychology literature about the relationship between social and 
nonsocial cognition is the building-block theory (Ostrom, 1984; Penn et al., 1997).  
Nonsocial and social cognition are related but represent different levels of analysis in that 
more basic cognitive processes provide the foundation for social cognitive processing.  
Based on this theory, neurocognitive deficits might be a limiting factor, but social 
cognition would have a more precise relationship to social functioning and outcome in 
that how an individual understands social behavior and interprets the world is more 
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closely related to his or her behavior. This theory contrasts with other social cognition 
theories that propose that social and nonsocial cognition involve identical processes 
(Ostrom, 1984).   
 Green & Nuechterlein (1999) proposed a model of the relationship between 
neurocognition and functional outcome in which social cognition was a mediator. Further 
research supports this model in that 1) social cognition and neurocognition are related but 
separate factors (Sergi et al., 2007), and 2) social cognition contributes variance to 
functioning above and beyond the contribution of neurocognition (Brekke, Kay, Lee, & 
Green, 2005; Sergi, Rassovsky, Nuechterlein, & Green, 2006). Therefore, neurocognitive 
abilities may affect the quality of patients’ social abilities and interactions, and this, in 
turn, is something that influences general functioning and life quality.   
Emotion Recognition  
 Emotion recognition is a widely researched domain of social cognition referring 
to the ability to decode emotions from facial expressions. The ability to recognize facial 
expressions of emotion is an important aspect of human social interactions. The ability 
develops very early in life, around one year of age (Sorce, Emde, Campos, & Klinnert, 
1985), and facial processing in general is neurally distinct from processing of other, non-
social objects (Aldolphs, 2002). Further, some facial expressions of emotion are invariant 
across cultures; happiness, sadness, anger, fear, disgust, and surprise (Ekman & Friesen, 
1971; Ekman, 1973; Izard, 1994).   
 A plethora of research studies have been conducted to examine emotion 
recognition in schizophrenia patients. Some reliable findings include that patients are 
more impaired in facial emotion recognition than controls (Dougherty, Bartlett, & Izard, 
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1974); this is related overall functional impairment (Mueser et al., 1996; Kee, Green, 
Mintz, & Brekke, 2003). Emotion recognition deficits may reflect a trait-like 
vulnerability marker for schizophrenia rather than a state-like deficit that can be 
attributed to symptoms. Support for this idea comes from studies that have found no 
improvement with symptom remission (Addington & Addington, 1998), no improvement 
with antipsychotic treatment (Herbener, Hill, Marvin, Sweeney, 2005), and deficits that 
remain stable over time (Addington, Saeedi, & Addington, 2006).  
Researchers have investigated different mechanisms possibly underlying emotion 
recognition deficits in schizophrenia. These include neurocognitive deficits, social 
cognitive biases, and symptom heterogeneity. Neurocognitive explanations have been 
most widely offered by researchers. Chapman and Chapman (1973) observed that 
individuals with schizophrenia exhibit a “generalized deficit” in cognitive tasks, meaning 
that their performance is worse than typical persons on most cognitive tasks, and 
suggested that this be taken into account when looking for more specific areas cognitive 
deficits. This generalized deficit makes it very likely that individuals with schizophrenia 
will show below average performance, whether or not they actually have a specific deficit 
in the domain being investigated. Researchers have addressed this problem in a number 
of ways, the most stringent control for the generalized deficit being the use of control 
tasks matched on every aspect other than the domain being tested. These tests should be 
psychometrically validated on individuals with schizophrenia. This allows for the control 
of general processing, responding, or encoding deficits present in schizophrenia.  
Researchers using this “differential deficit design” have disagreed on whether there is a 
specific emotion recognition deficit in schizophrenia. While many studies show that 
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patients are differentially impaired when processing emotions in facial expressions 
(Heimberg et al., 1992; Hall et al., 2004; Kucharska-Pietura et al., 2005; Schneider et al., 
2006), there is also compelling research to suggest patients have a generalized facial 
processing deficit (e.g. Kline, Smith & Ellis, 1992; Kerr & Neale, 1993;  Salem, Kring & 
Kerr, 1996;  Mueser et al., 1996; Addington & Addington, 1998; Kohler, Bilker, 
Hagendoorn, Gur, & Gur, 2000). It seems that neurocognition plays an important role in 
emotion recognition. However, given the inconsistent findings, neurocognition probably 
does not account for all of the difficulties, and it may do so in only some patients.   
 Another mechanism potentially underlying poor emotion recognition in 
schizophrenia is a social cognitive bias. Biases occur when individuals have a tendency to 
perceive stimuli in a particular way, such as a bias toward perceiving the faces as more 
negative, more positive, or more threatening.This idea is supported by research showing 
that individuals with schizophrenia make more errors than would be explained by 
neurocognitive limitations differential deficit), or that they may be consistently making 
certain types of errors. Several studies have investigated potential biases in emotion 
recognition and these issues have been examined in a number of different ways.   
First, many have considered whether patients are impaired when recognizing only 
particular emotions. This research has yielded many different findings with some 
supporting a deficit in recognizing positive emotions (Sachs, Steger-Wuchse, Kryspin-
Exner, Gur, & Katschnig, 2004), negative emotions (Kucharska-Pietura, David, Masiak, 
& Phillips, 2005), or threatening emotions such as anger or fear (Premkumar et al., 2008). 
Other researchers have examined the types of errors patients make. Some studies indicate 
that patients are more likely to perceive emotion in neutral faces (Heimberg et al., 1992; 
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Leppánen, Niehaus, Koen, Du Toit, Schoeman, & Emsley, 2006), especially negative 
emotion (Kohler et al., 2003). Still others have considered whether patients 
systematically perceive faces as being more negative or positive than they are considered 
by controls.  In some studies, patients show a bias toward viewing expressions as more 
positive (Dougherty et al., 1974; Schneider, Gur, Gur, & Shtasel, 1995). More recent 
studies using more lifelike emotion recognition tasks with a range of emotional intensities 
have revealed a negative bias (Kohler, Turner, Bilker, & Brensinger, 2003; Tsoi et al., 
2008). Prior research examining cognitive biases does not lead to any strong conclusions. 
However, this is not unexpected given the many correlates of patient status (i.e. heavy 
medication, social isolation, broad neurocognitive deficits) which could impact emotion 
recognition ability as well as the range of methodologies employed (discussed below).   
 Few studies have examined emotion recognition in different subtypes of 
schizophrenia in a systematic way that examines the full range of symptoms. However, 
many studies that attempt to examine different subtypes or symptom dimensions suggest 
that heterogeneity may be an important issue when studying emotion recognition deficits. 
It may be that only some patients have trouble recognizing facial emotions or different 
types of symptoms may be associated with different biases. For example, individuals with 
paranoid symptoms tend to be more accurate when recognizing facial emotions than 
nonparanoid individuals (Kline et al., 1992; Phillips et al., 1999). Mandal, Jain, Haque-
Nizamie, Weiss, & Schneider (1999) found that patients with positive but not negative 
symptoms exhibited a positive bias when identifying facial emotions. Schneider and 
colleagues (1995) also found that emotion recognition performance was negatively 
correlated with severity of negative symptoms and bizarre behavior. This suggests that 
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patients with different symptom presentations may approach emotion recognition tasks 
very differently. Further support for this is found in an article written by Cohen, Nienow, 
Dinzeo, and Docherty. (2009) in which, although error profiles in patients as a group and 
controls were similar, within patients, severity of positive symptoms was associated with 
fear misperceptions and severity of disorganization and negative symptoms was 
associated with anger misperceptions. Although the extant literature on subgroups of 
patients does not offer definitive conclusions, it highlights the importance of considering 
heterogeneity.   
  The emotion recognition literature has many limitations. While the effect of the 
generalized deficit may be replicable across studies, findings concerning differential 
deficit, biases, and subtypes are not. One reason for this may be that methods are not 
consistent across studies (see Edwards (2002) for a review). Many researchers have 
created their own emotion recognition tasks with different stimuli, response formats, and 
emotion categories. To address this issue, Kerr and Neale (1993) developed a 
standardized measure of emotion recognition, the Facial Emotion Identification Test 
(FEIT), which has been used in a number of studies since. While this offered some 
consistency of methods and represented an improvement over developing a new task for 
each study, the FEIT still has limitations. There are a limited number of stimuli, faces are 
restricted in ethnicity and age, stimuli contain actors depicting only posed expressions of 
emotion, and tasks do not control for emotion intensity of facial expressions.   
  In sum, there are many inconsistencies in the literature concerning emotion 
recognition abilities in patients with schizophrenia. The research is rife with 
methodological problems, including the use of nonstandardized tasks, emotional stimuli 
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limited in ethnicity and age, and inattention to the considerable heterogeneity of 
schizophrenia symptoms. Although there is substantial support for a deficit in emotion 
recognition performance in individuals with schizophrenia, it is questionable how 
meaningful this deficit is given general cognitive deficits. Moreover, the potential role of 
social cognitive biases has not been clarified. Finally, the question still remains whether 
emotion recognition deficits reflect general cognitive abilities in schizophrenic patients, 
or whether they are a vulnerability marker present even in individuals who have the 
genetic liability but do not show symptoms. These questions may be addressed by 
considering individuals at risk for schizophrenia.   
Schizotypy 
It has been proposed that schizophrenic symptoms are multidimensional and are 
present at subclinical levels in individuals who possess the underlying genetic 
vulnerability. Sandor Rado (1956; Rado & Daniels, 1956) first used the term 
“schizotype” to refer to an individual who had the schizophrenic phenotype. Rado viewed 
schizophrenia symptoms as continuous and present to a lesser degree in some individuals.   
Meehl (1962) refined this theory, focusing on what he called the “schizogene,” a gene 
that affected brain development which all individuals with schizotypy possess. Having 
this gene resulted in an integrative neural deficit and produced a central nervous system 
anomaly, which Meehl termed “schizotaxia.” The effect of schizotaxia in interaction with 
social learning and other environmental influences produces a schizotypal personality 
organization. Three phenotypic outcomes are possible for the schizotype: 1) schizotypy, 
2) schizophrenia spectrum disorder, or 3) schizophrenia. According Meehl’s model, 
about 10 percent of the general population has the genetic vulnerability, but only 5 
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percent of them will develop full-blown schizophrenia (Meehl, 1962; Lenzenweger & 
Korfine, 1992). Therefore, these individuals are at substantially increased risk for 
developing schizophrenia compared to the general population with a prevalence of 0.4 
percent). It is notable, also, that later conceptualizations of this model include polygenetic 
influences rather than a single gene (Lenzenweger, 2006). Probably the most important 
part of Meehl’s model is that those who do not decompensate will show the liability as 
subtle aberrations in psychological and neurocognitive processes. This theory has led to a 
myriad of studies examining risk markers, or endophenotypes, for schizophrenia 
(Gottesman & Gould, 2003). Meehl’s risk signs included cognitive slippage, 
interpersonal aversiveness, anhedonia, and ambivalence. These signs result from the 
central nervous system anomaly and are present in all who possess the schizogene, 
regardless of whether symptoms are manifest. Further research in schizotypy has 
supported Meehl’s model. Schizotypes can be reliably identified (Raine, 1991), 
taxometric studies indicate that a subset of the population exhibits schizotypal personality 
organization (Horan, Blanchard, Gangestad, & Kwapil, 2004), and this population is at an 
increased risk for schizophrenia and related disorders (Chapman, Chapman, Kwapil, 
Eckblad, & Zinser, 1994; Gooding, Tallent & Matts, 2005).   
Symptoms 
Schizotypy research has also revealed symptom dimensions similar to that of 
schizophrenia (Wuthrich & Bates, 2006; Rossi & Daneluzzo, 2002). Kerns (2006) found 
that a three factor model of schizotypy including positive, negative, and disorganization 
symptoms exhibited a good fit. This study included extensive schizotypy measures, 
assessing the full range of symptoms. Schizotypy symptom dimensions closely resemble 
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those of schizophrenia, only not severe enough to meet clinical threshold (Raine, 
Reynolds, Lencz, Scerbo, Triphon, & Kim, 1994). Positive schizotypy symptoms include 
ideas of reference, magical thinking, and paranoid ideation. Negative schizotypy includes 
having no close friends and constricted affect. Disorganized schizotypy is characterized 
by oddities of speech and behavior such as speech that uses vague or unclear references. 
Just as in schizophrenia, individuals may exhibit different degrees of each symptom 
dimension with different levels of functional impairment, including some that show little 
to no impairment.   
 Measurement of Schizotypy 
 Current research methods usually identify schizotypes in one of four ways: 
biological relatives of schizophrenia patients, individuals in the prodromal phase, 
individuals with schizotypal personality disorder, and individuals with psychometrically-
identified schizotypy. Studies using biological relatives identify patients with 
schizophrenia and assume biological relatives possess the genetic vulnerability (twins, 
siblings, parents). This method finds support in studies that have found that relatives are 
at increased risk for schizophrenia and display subclinical symptoms (Baron et al., 1985; 
Erlenmeyer-Kimling & Conblatt, 1987; Thaker, Adami, Moran, Lahti & Cassidy, 1993). 
Another method is the ultra-high-risk method which seeks to identify individuals who are 
on the verge of decompensation into schizophrenia (Simon et al., 2006). These 
individuals are already experiencing psychotic symptoms and some functional 
impairment but have not yet deteriorated to the point of meeting diagnostic criteria. This 
includes individuals with intermittent psychosis of a shorter duration, symptoms not 
intense enough to meet criteria, and individuals with combinations of trait and state 
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factors that put them at particular risk (Yung et al., 2003). Some research also uses 
diagnostic criteria for schizotypal personality disorder in which there is a clear diagnostic 
threshold, with symptoms either being present or not. Particular problems with these 
methods are first that they are not very efficient, and they capture only those individuals 
on one end of the schizotypy spectrum, largely ignoring those who never decompensate.  
According to Meehl’s model, the majority never decompensate. Finally, researchers also 
use a psychometric risk paradigm. The idea is to identify individuals with schizotypy 
based on behavioral or self-report measures of some of Meehl’s signs of schizotypy.  
This method has been used in many studies and has proven to efficiently capture a 
sample of individuals who are at a greater risk for developing schizophrenia and 
schizophrenia- spectrum disorders (Chapman et al., 1994; Kwapil, Miller, Zinser, 
Chapman, & Chapman, 1997; Gooding, Tallent, & Matts, 2007).  
One of the most widely used psychometric measures is the Schizotypal 
Personality Questionnaire (SPQ). Raine (1991) designed this questionnaire to mirror 
DSM-III symptoms of schizotypal personality disorder. While previous scales measured 
a limited number of symptoms (positive symptoms, speech disturbances, etc.), the SPQ 
assesses a range of symptoms, including all nine features of schizotypal personality 
disorder: ideas of reference, excessive social anxiety, odd beliefs/magical thinking, 
unusual perceptual experiences, odd/eccentric behavior, no close friends, odd speech, 
constricted affect, and suspiciousness. Although SPQ items mirror schizotypal 
personality disorder symptoms, it assesses a broad range of subclinical pathology rather 
than just clinically significant symptoms. The SPQ has demonstrated good internal 
reliability (! = .91) and test-retest reliability (r = .82). Further, it demonstrates criterion 
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related validity in that high scorers are much more likely to qualify for a diagnosis of 
schizotypal personality disorder, and all of those identified with schizotypal personality 
disorder obtained high scores (Raine, 1991). Raine (1991) also examined correlations 
between other schizotypy scales and scales related to schizotypy but not measuring DSM-
III schizotypal personality symptoms and found evidence for convergent and discriminant 
validity. The SPQ has also been factor analyzed, revealing three separate dimensions 
similar to those found in schizophrenia (Reynolds, Raine, Mellingen, Venables, & 
Mednick, 2000; Wuthrich & Bates, 2006).  
Overall, these results suggest that schizotypy is a construct similar in structure to 
schizophrenia, it reflects a vulnerability to schizophrenia, and can be revealed via 
relatively brief self-report questionnaires. Research with individuals at risk allows 
researchers to avoid many confounds associated with chronic patients, including severe 
cognitive deficits, medication effects, hospitalization, and acute psychosis.   
Neurocognition  
Schizotypy research has often revealed a wide range of neurocognitive deficits, 
however, these deficits are not as large as those found in schizophrenia (Siever & Davis, 
2004). Particular areas of impaired neurocognition include those found in schizophrenia 
patients: verbal memory, attention, and executive functioning (Sitskoorn, Aleman, 
Ebisch, Appels, & Kahn, 2004). This comes from studies that have examined individuals 
with schizotypal personality disorder (Voglmaier, Siedman, Niznikiewicz, Dickey, 
Shenton, & McCarley, 2005; Siever, Koenisgerg, Harvey, Mitropoulou, Laruelle, Abi-
Dargham et al., 2002, Roitman, Bergman, & Obuchowski, 1997), biological relatives of 
schizophrenia patients (Sitskoorn et al., 2004; Laurent, Biloa-Tang, Bougerol, Duly, 
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Anchisi, Bosson et al., 2000), ultra-high-risk samples (Wood, Pantelis, Proffitt, Phillips, 
Stuart, Buchanan, et al., 2003; Brewer, Francey, Wood, Jackson, Pantelis, Phillips et al., 
2005), and some psychometric high risk samples (Barrantes-Vidal, Fananas, Rosa, 
Caparros, Riba, & Obiols, 2002; Bergida & Lenzneweger, 2006, but see Jahshan & Sergi, 
2007: Lenzenweger & Gold, 2000). In summary, although broad neurocognitive deficits 
have been identified in schizotypy samples and do appear to be associated with risk for 
schizophrenia, these deficits are not as profound as those found in individuals with 
schizophrenia. 
Social Cognition  
Individuals with schizotypy also exhibit some social cognitive deviations. 
However, social cognition has not been widely investigated in at risk samples. Some 
studies, which will be discussed later, have offered evidence for abnormalities in emotion 
recognition, but the bulk of the literature is inconclusive. Research has shown that 
individuals with schizotypy may have difficulty making social inferences (Irani, Platek, 
Panyavin, Calkins, Kohler, Siegel, 2006; Marjoram, Miller, McIntosh, Owens, Johnstone, 
& Lawrie, 2006; Chung, Kang, Shin, Yoo, & Kwon, 2008; Pickup, 2006), interpreting 
nonverbal cues (Toomey, Seidman, Lyons, Faraone, & Tsuang, 1999), and may make 
deviant attributions for social/interpersonal events (Levine, Jonas, Serper, 2004). There 
have been studies contradicting these findings, however (Kelemen, Must, & Benedek, 
2004; Fernyhough, Jones, Whittle, Waterhouse & Bentall, 2008; Jahshan & Sergi, 2007).   
 Most notable is the dearth of research in this area and the lack of consistency 
between studies.  There have been relatively few studies examining the different domains 
of social cognition, and these studies have used different methods of conceptualizing and 
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identifying schizotypy as well as different ways of measuring social cognitive constructs. 
Furthermore, studies have not systematically examined heterogeneity within schizotypy, 
so we do not know whether particular symptoms are related to social cognition. Studies 
mentioned above have either used restricted schizotypy samples or have not 
differentiated between symptom domains.   
Emotion Recognition  
A few studies examining emotion recognition in individuals with schizotypy have 
not found a deficit compared to controls (Pinkham et al., 2007; Toomey & Schuldberg, 
1995; Shean, Bell, & Cameron, 2007). However Kee, Horan, Mintz, and Green (2004) 
found that across facial, vocal, and combined emotion recognition tasks individuals at 
risk for schizophrenia were impaired relative to controls, but not as impaired as 
individuals with schizophrenia. Individual studies may either not be sensitive enough to 
detect the effect and issues such as neurocognitive limitations, social cognitive biases, 
and/or symptom heterogeneity may complicate this line of research.   
 Research with individuals with schizotypy raises the same issues as research with 
individuals with schizophrenia. This first possibility is that individuals with schizotypy 
are worse than healthy individuals at recognizing facial emotions due to neurocognitive 
limitations such as visual processing or attention. Second, individuals may be biases 
when perceiving emotion in faces, tending to see faces as either threatening or negative.  
Third, possibly only some subset of individuals with schizotypy are impaired or different 
subgroups may exhibit different patterns of accuracy or bias. These issues have been 
examined in part by some researchers.   
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 Although, as mentioned above, many studies have shown neurocognitive 
impairment in individuals with schizotypy, some have not. Any study examining emotion 
recognition ideally would include a measure of broader cognitive abilities to control for 
this. Some studies have done this. Two find on emotion recognition deficits and no 
neurocognitive impairment (Toomey et al., 1999; Jahshan & Sergi, 2007). However, one 
study finding that college students with schizotypy were impaired on emotion recognition 
tasks concluded that this was explained by a general attention deficit (Poreh, Whitman, 
Weber, & Ross, 1994). This has not been replicated.   
 Given that individuals with schizotypy are not as impaired across the board as are 
individuals with schizophrenia, they may employ compensatory strategies when decoding 
emotions with from facial expressions. Therefore, difficulty recognizing emotions may 
not be evident from accuracy scores alone. One way to examine this is to consider 
whether individuals with schizotypy exhibit any underlying social cognitive biases when 
perceiving facial expressions. Couture, Penn, Addington, Woods, and Perkins (2008) 
found high-risk participants showed a bias toward rating faces as being more trustworthy 
than controls did. Leppanen, Niehaus, Koen, Du Toit, and Emsley’s (1998) participants 
exhibited similar patterns as their siblings with schizophrenia when labeling emotions in 
faces: impaired recognition of negative emotions. Relatively intact neurocognitive 
abilities may enable some individuals to overcome these types of biases when labeling 
emotions. To date, little research has been conducted in this area.   
 Performance deficits and biases may also be obscured by the considerable 
symptom heterogeneity in schizotypy. Particular symptoms may be associated with 
impairments. Most studies have not considered the full range of symptoms, but a few 
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suggest there may be differences. Positive schizotypy is associated with emotion 
recognition errors in one study (Wout, Aleman, Kessels, Laroi, & Kahn, 2004) and with 
an attentional bias towards threatening facial expressions in another (Green, Williams, & 
Davidson, 2001). To date, one study including the full range of symptoms has found 
evidence for emotion recognition deficits. Williams, Henry, and Green (2007) found that 
high and low schizotypy groups (defined as those scoring in the upper fifteenth and lower 
fifteenth percentiles from a sample of 843 college students) did not differ when required 
to choose from a list which emotion a face was expressing but did differ in a task 
requiring that they choose one of eight faces that matched the emotion in a target faces 
(discrimination task). This was found after controlling for facial identity recognition. The 
authors interpreted this as reflecting a trait deficit, and it was particularly associated with 
negative symptoms. This study used previously validated emotion recognition stimuli, 
but it had a relatively small sample size (28 schizotypy and 28 controls), and used a brief 
version of the SPQ with weaker psychometric properties than the full version (Compton, 
Chien, & Bollini, 2007). These results need replication in larger samples using more 
psychometrically sound measures.   
 It is unclear from the existing literature whether individuals at risk for 
schizophrenia are impaired at facial emotion recognition. The prior literature is subject to 
a number of limitations including the use of instruments ill-equipped to measure emotion 
recognition ability, poor attention to the full range of schizotypal symptoms, and small 
sample sizes. A handful of studies have found impairments in emotion recognition in this 
population, suggesting that no single study has enough power to detect this difference, 
the emotion recognition tasks are not sensitive enough, or combining all individuals with 
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schizotypy into one group without considering heterogeneity may obscure real deficits in 
particular subtypes. The current study was designed to address the methodological issues 























The current study examines whether individuals with schizotypy have a facial 
emotion recognition deficit and how this relates to neurocognition, social cognitive 
biases, and overall functioning. A relatively large sample of individuals with 
psychometrically-identified schizotypy and normal controls are included to compare 
these groups of individuals on a well-validated emotion recognition task allowing for 
quantification of accuracy and positive and negative bias. In order to determine whether 
poor emotion recognition can be explained by neurocognitive deficits, I include a 
measure of broad neurocognitive abilities. Measures of schizotypy symptoms and 
subjective and objective measures of overall life quality are also employed in order to 
compare the schizotypy and control groups on these measures and determine, within the 
schizotypy group, the relationship between emotion recognition, neurocognition, social 
cognition, symptoms, and life quality.  Specific research questions and hypotheses 
follow.   
Research Questions and Hypotheses 
1. Are individuals with schizotypy different from healthy controls on emotion recognition 
or neurocognitive ability?   
Hypothesis 1a: Individuals with schizotypy will perform worse than controls on 
measures of neurocognitive ability.   
Hypothesis 1b: Individuals with schizotypy will be less accurate than healthy 
controls on measures of emotion recognition accuracy.   
Hypothesis 1c: Individuals with schizotypy will show a negative bias when 
 looking at facial expression of emotion relative to controls.   
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2. Is emotion recognition related to impaired neurocognitive ability in individuals with 
schizotypy?   
Hypothesis 2: In individuals with schizotypy, emotion recognition accuracy will 
be positively correlated with neurocognitive ability.   
3. Are different types of schizotypy differentially related to emotion recognition, and to 
what degree does this reflect neurocognitive deficits?   
Hypothesis 3a: Emotion recognition will exhibit different relationships to 
different schizotypy symptoms.   
Hypothesis 3b: Biases in emotion recognition will be associated with some 
symptom dimensions, but not others.   
Hypothesis 3c: The relationship of symptoms to emotion recognition bias will 
remain significant when controlling for neurocognitive abilities.   
4. Is emotion recognition related to quality of life in individuals with schizotypy, and to 
what degree does this reflect neurocognitive deficits?   
Hypothesis 4a: Emotion recognition accuracy will be associated with poorer 
quality of life 
Hypothesis 4b: Negative bias will be associated with poorer quality of life 
Hypothesis 4c: The relationship between emotion recognition, bias, and quality of 







Participants   
An online questionnaire was sent via email to 8,993 freshman and sophomore 
undergraduates at Louisiana State University as part of a larger study. Those who 
completed the questionnaire were entered into a lottery of ten possible $25 prizes. 1775 
students responded resulting in 1395 complete profiles. The questionnaire consisted of a 
consent form, demographic questions, and the SPQ. Those subjects with positive, 
negative, or disorganized scores in the 95th percentile (based on gender and ethnicity 
norms) were invited to participate further in the laboratory phase of the study. Of these 
individuals, seventeen were recruited based on high positive scores, 32 based on high 
negative scores, and 26 were recruited based on high disorganization scores. Some 
individuals were recruited based on high scores on more than one factor including two 
with both high disorganization and negative scores, eight with high disorganization and 
positive scores, two with high negative and positive scores, and finally two participants 
had high scores on all three factors. We also identified individuals with scores below 
gender and ethnicity means on the SPQ subscales whom we recruited as a control group.  
There were no other exclusionary criteria. All participants in this phase of the study 
received 20 dollars cash compensation and the possibility of extra credit toward 
psychology courses. The final sample included 91 participants in the schizotypy group 
and 27 participants in the control group. Participants were tested by trained 
undergraduate research assistants. Participants were assessed with the instruments noted 
here as well as and a variety of other instruments. Testing sessions lasted approximately 
two hours. Two participants in the schizotypy group were excluded based on incomplete 
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profiles, resulting in a final sample of 89 participants in the schizotypy group. In addition, 
one participant in the control group did not complete two of the measures mentioned 
below, resulting in some analyses being conducted with 26 controls. This study was 
approved by the Louisiana State University Human Subject Review Board and all 
subjects offered informed consent prior to completing the surveys. 
Measures 
Schizotypal Personality Questionnaire (SPQ)   
In order to select participants and measure symptomology, the SPQ was used.  
The SPQ, as described above, is a 74-item, self report questionnaire that assesses the full 
range of schizotypal personality disorder symptomotology (DSM IV-TR; Raine, 1991) 
(see Appendix A for individual items and scoring). It has demonstrated good 
psychometric properties as well as convergent and discriminant validity. The SPQ is easy 
to administer to large groups and yields a large amount of data.  It has been used in a 
large number of studies and is preferred over other similar instruments because it has 
superior psychometric properties (Raine, 1991), assesses a large range of symptoms that 
are closely related to DSM IV-TR symptoms, and is relatively brief.    
 Participants responded using a five-point Likert scale ranging from “strongly 
disagree” to “strongly agree.” Likert scale versions have been shown to highly correlated 
with the traditional format (r =.88-.94), and show superior internal reliability (Wuthrich 
& Bates, 2005). Likert versions may be better able to detect individuals less inclined to 
disclose symptoms as well as identifying “false alarms” (Wuthrich & Bates, 2005). Given 
research that has consistently shown that SPQ measured schizotypy is composed of three 
factors (Raine et al., 1994; Chen, Hsiao & Lin, 1997; Reynolds et al., 2000), we 
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employed dimensional scores reflecting positive, negative, and disorganized schizotypy 
for each participant.     
Lehman’s Quality of Life Brief Interview (QoL-I)   
Quality of life was assessed with the QoL-I, a self-report questionnaire that 
includes items that assess an individual’s subjective perception of his/her quality of life 
as well as objective items assessing activities and social supports (Lehman, 1995). This 
measure has previously been used in research involving psychiatric populations 
(Wasserman, Sorensen, Delucchi, Masson, & Hall, 2006; Heider et al. 2007; Anderson, 
McNeil, & Reddon, 2002) and has demonstrated good psychometric properties (Lehman, 
1996). The brief version includes 78 items, and the amount of administration time was 
not feasible for our research purposes. We used the even briefer version used by Bellack, 
Bennett, Gearon, Brown, and Yang (2006) which includes 33 items, allowing for 
computation of seven scales: home concerns, daily activities, family relationships, social 
relationships, financial concerns, legal concerns, health concerns, and global life quality 
in two domains: objective quality of life and subjective quality of life (see Appendix B). 
Increasing scores reflect increasing quality of life.   
Penn Emotion Recognition Test (PERT)  
Emotion recognition was measured using the 40-item PERT (Gur et al., 2002; 
Kohler et al., 2003). The items include both high and low intensity angry, fearful, happy, 
sad, and neutral faces. These faces represent a diversity of ethnicity and age and include 
both posed and evoked expressions (see Appendix D for an example of stimuli). The task 
presents each face one at a time and participants are asked to choose which emotion is 
being expressed from a list of six choices (happy, sad, disgust, fear, anger, no emotion) 
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reflecting five of the six universal emotions according to Ekman and Friesen (1975). The 
PERT authors did not include one emotion, surprise, in the list because they claimed it is 
not a “pure” emotion, saying “its valence depends entirely on the triggering event and it 
can be any of the other emotions, with a rapid onset” (Kohler et al., 2003).  An additional 
component was added in which participants rated how positive or negative each face 
looked.  Participants made this rating using the Semantic Affective Moniker (Lang, 
Bradley, & Cuthbert, 2005), an analogue scale ranging from one (good mood) to nine 
(bad mood) (see Appendix D).    
Repeatable Battery for the Assessment of Neuropsychological Status 
 (RBANS) 
 
The RBANS was used as a broad measure of neurocognitive functioning. 
Randolph, Tierney, Mohr, and Chase (1998) originally developed the RBANS as a 
screener for use with individuals with schizophrenia and dementia. Other researchers 
have used it in various populations since, including individuals with anorexia nervosa 
(Mikos et al., 2008), elderly adults (Duff, Schoenberg, Mold, Scott, & Adams, 2007), and 
athletes (Killam, Cautin, & Santucci, 2005). It has also been useful as an assessment of a 
range of abilities in individuals with schizophrenia (Gold, Queern, Iannone, & Buchanan, 
1999; Wilk et al., 2002). The RBANS has demonstrated particular efficacy as a brief 
measure of broad neurocognitive functioning in schizophrenia. The test is sensitive 
enough to detect impairments in patients, performance is highly related to outcome, it is 
reliable (Gold et al., 1999), and has demonstrated convergent and discriminant validity in 





Analyses were conducted in several steps. First the schizotypy and control groups 
were compared on demographic and clinical variables. Next, hypothesized group 
differences were examined on variables of interest. Finally, neurocognition, emotion 
recognition, symptoms, and quality of life were examined within the schizotypy group 
with correlational analyses. All variables were normally distributed (skew scores > 1.5) 
unless otherwise noted.   
Power for each of these analyses was examined using G*Power software 3.0.10.  
This study was powered to detect group differences at an effect size of d = .55 using a 
one-tailed t test with an ! level of .05 and a power of " = .80. Medium effect sizes were 
expected given the use of a more sensitive, well-validated emotion recognition measure.  
Previous studies conducted on individuals with schizophrenia have found either large or 
medium effects (d = .53-.97) using the less sensitive FEIT (Addington et al., 2006; 
Mueser et al., 1996). Schizotypy studies have generally found smaller effect sizes when 
looking at emotion recognition accuracy (Williams et al., 2007; Kee et al., 2004) except 
for Poreh and colleagues (1994) who found effect sizes up to d = .88 with individual 
emotion categories. In partial support, studies that have found biases when looking at 
facial emotions have found medium effects (d = .67 - .72) (Green et al., 2001; Couture et 
al., 2008). Within schizotypy analyses here are powered to detect small to medium effects 
(r = .29) using two-tailed tests with a power of " = .80 and ! = .05.  Previous schizotypy 
studies in emotion recognition have also been powered to detect small to medium 
correlations (Jahshan & Sergi, 2007; Williams et al., 2007), and given improved methods 





I first examined group differences on demographic variables.  The schizotypy 
group was 30.30% male and 87.60% Caucasian.  The control group had slightly more 
males (49.10%) and less Caucasian participants (77.80%). Age was positively skewed 
(skew = 5.06), therefore a nonparametric Man-Whitney U test was employed, revealing 
that the groups were similar in age (U = 1092.50, n.s.).   
Table 1.  Means and Standard Deviations (M(SD)) for Demographic and Clinical 
Variables for Schizotypy and Control Groups 
 
 Schizotypy (n = 89) Controls (n = 27) t p 
% male 30.30 48.10   
% Caucasian 87.60 77.80   
Age 19.19 (1.39) 19.81 (3.25) 1092.50 3 .45 
SPQ total1 1.41 (0.58) -1.94 (0.35) -36.83* .00 
SPQ positive1 1.14 (0.92) -1.75 (0.35) -24.46* .00 
SPQ negative1 1.28 (1.02) -1.43 (0.34) -21.40* .00 
SPQ disorganization1 1.27 (0.79) -1.64 (0.51) -22.58* .00 
QOL subjective2 30.41 (6.41)  39.96 (4.94) 7.01 (113)* .00 
QOL objective2 -3.93 (5.65) 2.04 (3.97) 6.08 (57.51)* .00 
* p < .01, 1z scores based on gender and ethnicity means, 2n = 26 controls, 3 Mann Whitney U, SPQ = 





Clinical Variables  
Group differences on clinical variables were tested with a series of one-tailed 
independent t-tests.The schizotypy group demonstrated a range of symptomology, with 
significant levels of positive, negative, and disorganized schizotypy traits.The schizotypy 
group as a whole also reported poorer quality of life in both the objective (t (113) = 6.08, 
p < .01) and subjective domains (t (113) = 7.01, p < .01). Demographic and clinical 
variables are presented in Table 1.  
Neurocognition 
Contrary to my hypothesis, a one-tailed independent t-test revealed that the 
schizotypy group did not differ from the control group on general neurocognitive ability 
as measured by the RBANS, (t (113) = -0.93, n.s.). As these results were unexpected 
given prior research, I conducted additional two-tailed t-tests with the individual RBANS 
indexes as dependent variables. Groups also did not differ on any of the individual 
indexes other than Immediate Memory, on which the schizotypy group performed 
significantly better than the control group (t (113) = -2.20, p < .05). A trend was also seen 
on the Attention index in which the control group performed better than the schizotypy 
group (t (113) = 1.69, p =.10). Means and standard deviations are presented in Table 2.   
Emotion Recognition 
Differences between the schizotypy and control group on PERT accuracy and 
valence ratings were examined with one-tailed independent t-tests. As expected, the 
schizotypy group was significantly less accurate than the control group when labeling the 
emotion of faces (t (114) = 3.22, p < .01) at a medium effect size (d = .74). The 
hypothesis that the schizotypy group would show a negative bias in their ratings of the 
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valence of the faces compared to the control group was not supported (t (114) = -0.95, 
n.s.). Results are presented in Table 3.   
Table 2. Means and Standard Deviations (M (SD)) for RBANS Index Scores in the 




Control (n=26) t p 
Visuospatial/Constructional  96.87 (16.38) 95.50 (19.43) -0.36 .72 
Immediate Memory 97.79 (12.46) 91.81 (11.15) -2.20 .03 
Delayed Memory 97.89 (10.39) 94.42 (12.61) -1.42 .16 
Language 92.16 (14.06) 94.73 (8.61) 1.14 .26 
Attention 99.67 (14.23) 105.50 (15.75) 1.69 .10 
RBANS Total Index 95.46 (11.67) 94.65 (11.17) -0.32 .75 
 
Table 3. Means and Standard Deviations (M (SD)) for PERT Scores in the Schizotypy 
and Control Groups 
 
 Schizotypy (n=89) Control (n=27) t p 
PERT Accuracy 69.13% (10.25) 76.20% (9.05) 3.22 .00 
PERT Valence 5.74 (0.45) 5.65 (0.39) -0.95 .35 
 
Within Schizotypy 
The following analyses include only the schizotypy group. The control group was 
not included here as the schizotypy and control groups are treated and recruited as 
conceptually different groups of individuals and processes applicable to one group are not 
assumed to apply to the other. In order to examine the hypothesized relationship between 
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emotion recognition and neurocognition, I computed Pearson’s r correlations between 
neurocognitive performance and emotion recognition accuracy. There was no relationship 
between RBANS index scores and PERT accuracy scores (all p’s > .05). As the 
hypothesized relationship was not found, it was unnecessary to conduct further analyses 
controlling for RBANS performance. Data are presented in Table 4.   

















.07 --     
Immediate 
Memory 
.10 .18 --    
Delayed 
Memory 
.12 .41** .43** --   
Language -.08 .13 .11 .15 --  




.07 .66** .59** .68** .52** .60** 
* p < .05 
** p < .01 
 
I examined the relationship between emotion recognition symptoms next.  As 
SPQ scores were ordinal data (not on a precise scale), I used Spearman’s rho correlations.  
The hypothesis that emotion recognition accuracy would be differentially related to the 
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examined symptom dimensions was not supported; there was no correlation between 
symptoms and emotion recognition accuracy (all p’s > .05). PERT valence ratings, 
however, were positively correlated with only SPQ disorganization (r = .31, p < .05); 
more negative ratings were associated with higher levels of disorganization symptoms.  
All other correlations were nonsignificant (all p’s < .05). Table 5 contains these 
correlations.   
Table 5.  Spearman’s Correlations Between SPQ Factors and PERT Variables 
 SPQ positive SPQ negative SPQ disorganization 
SPQ Positive --   
SPQ Negative -.29* --  
SPQ Disorganization .11 -.36* -- 
PERT Accuracy -.02 .11 -.14 
PERT Valence .16 -.08 .31* 
* p < .05 
Next I considered the relationship between PERT variables and quality of life. 
This was done using Pearson’s r correlations, except when examining PERT valence 
ratings; Spearman’s correlations were used for valence ratings as these are ordinal data. 
PERT accuracy scores were unrelated to quality of life (all p’s > .05). There was, 
however, a relationship between PERT valence ratings and quality of life. Subjective 
quality of life was negatively correlated with PERT valence ratings; increasing negative 
ratings were associated with poorer quality of life (r = -.24). All other correlations were 
nonsignificant (all p’s > .05). Follow-up investigation of these same correlations within 
the control group revealed no such relationship between PERT variables and subjective 
or objective quality of life (all p’s > .05), although these analyses were probably 
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underpowered because of the small number of controls in the study.  Correlations for the 
schizotypy group are presented in Table 6. 










PERT Accuracy --    
PERT Valence .05 --   
QOL objective -.19 -.01 --  
QOL subjective -.12 -.24* .36* -- 

















Facial emotion recognition is an important aspect of social interaction that 
emerges early in development and allows individuals to communicate and interpret their 
social worlds. This skill has been widely investigated in individuals with schizophrenia.  
Research has consistently shown that this ability is impaired in these individuals and that 
this impairment has a large impact on functional outcome. Despite the large body of 
existing research, many questions remain. Specifically, it is unclear whether poor 
emotion recognition represents a specific area of deficit or a more generalized deficit and 
whether this deficit reflects a state-like vulnerability present in individuals at risk for 
developing schizophrenia. The current literature involving individuals with schizophrenia 
has not provided clear answers to these questions for two reasons, confounds associated 
with research on chronically, severely mentally ill individuals and limited methodology.  
The few studies that have investigated emotion recognition in at-risk samples, while 
offering substantial insight into this phenomenon, have also employed limited samples 
and methodology.   
The current study investigated emotion recognition in college students at risk for 
developing schizophrenia identified by responses on a self-report questionnaire. This 
study addresses prior limitations in that it avoids confounds associated with severe mental 
illness by using a relatively unimpaired sample, includes a broad range of schizotypal 
symptomology similar to that seen in schizophrenia, and uses an improved facial emotion 
recognition task including more culturally representative stimuli, and examined 
subjective ratings in addition to facial emotion identification accuracy scores. 
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As predicted, the current study revealed impaired facial emotion recognition abilities in 
individuals with schizotypy. The present data provide intriguing evidence that emotion 
recognition deficits reflect an important vulnerability marker for schizophrenia-spectrum 
pathology. These deficits were present in the schizotypy group as a whole, and accuracy 
recognizing emotions was unrelated to any specific schizotypy trait. Deficits were not 
associated with particular schizotypy traits nor can they be attributed to the effects of 
severe mental illness such as medication or hospitalization.   
Unexpectedly, our schizotypy group did not show a broad deficit in 
neuropsychological tasks. In fact, on the immediate memory index the schizotypy group 
performed significantly better than the control group. Although most schizotypy research 
has found some evidence of neurocognitive impairment in individuals with schizotypy 
compared to controls, as mentioned above this has not been true of all research with 
psychometric schizotypy. At least two studies have failed to find neurocognitive deficits 
in individuals with psychometrically-defined schizotypy (Jahshan & Sergi, 2007; 
Lenzenweger & Gold, 2000). These studies also used university samples. It is possible 
that psychometric schizotypy does not overlap completely with schizophrenia 
vulnerability. However, given the large body of research supporting this method 
(Chapman et al., 1994; Kwapil, Miller, Zinser, Chapman, & Chapman, 1997; Gooding, 
Tallent, & Matts, 2007), it is unlikely that these individuals are not at increased risk.  
More likely is that college students with schizotypy may represent the least impaired 
individuals and/or have a number of protective factors such as high intelligence, better 
memory, or limited environmental stressors that have allowed them to overcome other 
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difficulties associated with genetic vulnerability. It may be only those individuals with 
these strengths that are able to function in a college environment.   
While schizotypy as a group did not show a systematic valence bias, 
disorganization symptoms were related to subjective perception of emotional faces as 
being more negative. This is consistent with what has been observed more generally for 
patients with schizophrenia – that patients with disorganization tend to report seeing faces 
as being angry (Cohen et al., 2009). This raises two important issues for future research 
to consider.  First, combining schizotypy into one group potentially obscures differences 
between individuals with different symptoms. Second, previous studies that have not 
examined the full range of schizotypy may produce results that apply to only a particular 
subtype and not to schizotypy as a whole. Since disorganized schizotypy traits are often 
not assessed in schizotypy studies (e.g., those using the other self-report schizotypy 
scales (Chapman et al., 1995)), it is critical that one employ instruments that assess a full 
range of schizotypal traits.  
One of the more general concerns of this study was whether or not facial emotion 
recognition ability was related to general quality of life. Our results suggest that while 
individuals with schizotypy may be less accurate at recognizing emotions, this is 
unrelated to quality of life. Rather, their subjective appraisals of the mood of emotional 
faces are related to self-reported quality of life. It is those individuals who see more 
negative faces that also say their quality of life is lower. Perceiving others’ emotions as 
negative could have an impact on social enjoyment, or feeling that one’s life is not 
enjoyable (perhaps due to symptoms) may lead individuals to see the social world as 
more negative. Biased interpretation of emotional valence in faces may be a factor that 
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leads to social misunderstandings such as misinterpretation of others’ intentions, failure 
to comprehend social situations, and trouble learning how to react to and express 
emotions. It may also affect the development of social schema that accurately predict 
others’ behavior. This could offer explanations for why many individuals with schizotypy 
report less enjoyment in social situations (Kwapil, 1998; Horan et al., 2007) and may be 
less accurate in interpreting social cues (Meehl, 1990; Kendler et al., 1995).   
While the PERT is an improvement over other existing facial emotional stimuli 
and shows promise as a more sensitive measure of emotion recognition, especially in 
individuals less impaired than patients with schizophrenia, it still does not approximate 
the manner in which facial expressions of emotion are experienced in daily life.  Using 
dynamic rather than static emotional expressions may reveal further emotional processing 
abnormalities (Archer et al., 1994). Emotional expressions are also often accompanied by 
a variety of body movements and contextual cues which are used to interpret emotion.  
The use of stimuli that more closely resemble faces encountered outside of the laboratory 
would increase external validity of future studies.   
Also of note is that this study did not allow for determination of “differential 
deficit” as mentioned in the introduction. While the schizotypy group did not show broad 
neurocognitive impairments, it is possible that subtle impairments in processes such as 
facial recognition or visual scanning/attention may be responsible for emotion 
recognition deficits. While the schizotypy group did not differ significantly from the 
control group on the attention index of the RBANS, performance was lower in this area. 
Attention is also a function that previous research has shown is related to emotion 
recognition in schizophrenia (Bryson, Bell, & Lysaker, 1997; Addington & Addington, 
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1998; Kee et al., 1998; Kohler et al., 2000; Combs & Gouvier, 2004) and in schizotypy 
(Poreh et al., 1994).  More sensitive measures of attention such as that used by Combs 
and Gouvier (2004) may reveal significant differences, and would allow for closer 
examination. Further research using matched control tasks is needed to examine these 
variables and to conclusively determine whether a differential deficit is demonstrated.   
In summary, our results support previous research suggesting that poor emotion 
recognition is associated with vulnerability to psychosis (Kee et al., 2004; Williams et al., 
2007). Emotion recognition appears to be impaired in all individuals at risk for 
schizophrenia as it is unrelated to symptoms. Furthermore, emotion recognition is related 
to functioning even in those individuals who are relatively unimpaired globally.  
Although the precise mechanisms involved are still unclear, this study offers evidence 
that emotion recognition is impaired even when broad neurocognitive deficits are not 
seen, and that this may be related to more social cognitive processes. Finally, more 
research is needed to delineate the relationships between emotion recognition processes, 
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Schizotypal Personality Questionnaire 
All responses were indicated on a 5-point Likert scale ranging from -2 strongly disagree, 
-1 disagree, 0 neutral, 1 agree, 2 strongly agree.  Increasing scores reflect increasing 
levels of the relevant trait.  All items were combined to compute a total schizotypy score. 
Positive schizotypy = sum of Ideas of Reference, Odd beliefs/Magical thinking, Unusual 
Perceptual Experiences, Suspiciousness 
Disorganized schizotypy= sum of Odd Behavior and Odd Speech 
Negative schizotypy= sum of Social Anxiety, No Close Friends, Constricted Affect, 
Suspiciousness 
 Items for each schizotypy factor are listed below.   
 
Ideas of Reference 
Do you sometimes feel that things you see on the TV or read in the newspaper have a 
special meaning for you? 
Have you ever noticed a common event or object that seemed to be a special sign for 
you? 
Do you sometimes see special meanings in advertisements, shop windows, or in the way 
things are arranged around you? 
I am aware that people notice me when I go out for a meal or to see a film. 
Do some people drop hints about you or say things with a double meaning? 
When shopping, do you get the feeling that other people are taking notice of you? 
When you see people talking to each other, do you often wonder if they are talking about 
you? 
Do you sometimes feel that other people are watching you? 
Do you sometimes feel that people are talking about you? 
Odd Beliefs/Magical Thinking 
Have you had experiences with the supernatural? 
Do you believe in telepathy (mind-reading)? 
Are you sometimes sure that other people can tell what you are thinking? 
Do you believe in clairvoyance (psychic forces, fortune telling)? 
Can other people feel your feelings when they are not there? 
Have you had experiences with astrology, seeing the future, UFO's, ESP, or a sixth 
sense? 
Have you ever felt that you are communicating with another person telepathically (by 
mind-reading)? 
 
Unusual Perceptual Experiences 
Have you often mistaken objects or shadows for people, or noises for voices? 
 53 
Have you ever had the sense that some person or force is around you, even though you 
cannot see anyone? 
When you look at a person or yourself in a mirror, have you ever seen the face change 
right before your eyes? 
I often hear a voice speaking my thoughts aloud. 
Have you ever seen things invisible to other people?  
Do everyday things seem unusually large or small? 
Does your sense of smell sometimes become unusually strong? 
Do you ever suddenly feel distracted by distant sounds that you are not normally aware 
of? 
Are your thoughts sometimes so strong that you can almost hear them. 
 
Suspiciousness 
I am sure I am being talked about behind my back. 
Do you often feel that other people have it in for you? 
Do you sometimes get concerned that friends or co-workers are not really loyal or 
trustworthy? 
I feel I have to be on my guard even with friends. 
Do you often pick up hidden threats or put-downs from what people say or do? 
Have you found that it is best not to let other people know too much about you? 
I often feel that others have it in for me. 
Do you often have to keep an eye out to stop people from taking advantage of you? 
 
Odd Behavior 
Other people see me as slightly eccentric (odd). 
People sometimes comment on my unusual mannerisms and habits. 
Sometimes other people think that I am a little strange. 
Some people think that I am a very bizarre person. 
I am an odd, unusual person. 
I have some eccentric (odd) habits. 
People sometimes stare at me because of my odd appearance. 
 
Odd Speech 
People sometimes find it hard to understand what I am saying. 
I sometimes jump quickly from one topic to another when speaking. 
I sometimes forget what I am trying to say. 
I often ramble on too much when speaking. 
Some people find me a bit vague and elusive during a conversation. 
I sometimes use words in unusual ways. 
Do you tend to wander off the topic when having a conversation? 
I find it hard to communicate clearly what I want to say to people. 
People occasionally comment that my conversation is confusing. 
 
Social Anxiety 
I sometimes avoid going to places where there will be many people because I will get 
anxious. 
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I get very nervous when I have to make polite conversation. 
Do you ever get nervous when someone is walking behind you? 
I get anxious when meeting people for the first time. 
Do you often feel nervous when you are in a group of unfamiliar people? 
I feel very uncomfortable in social situations involving unfamiliar people. 
I would feel very anxious if I had to give a speech in front of a large group of people. 
I feel very uneasy talking to people I do not know well. 
 
No close Friends 
I have little interest in getting to know other people. 
I prefer to keep myself to myself. 
I am mostly quiet when with other people. 
I find it hard to be emotionally close to other people 
Do you feel that there is no one you are really close to outside of your immediate family, 
or people you can confide in or talk to about personal problems? 
Writing letters to friends is more trouble than it is worth 
I tend to keep in the background on social occasions 
I attach little importance to having close friends. 
Do you feel that you cannot get "close" to people. 
 
Constricted Affect 
People sometimes find me aloof and distant. 
I am not good at expressing my true feelings by the way I talk and look. 
I rarely laugh and smile. 
My "nonverbal" communication (smiling and nodding during a conversation) is not very 
good. 
I am poor at returning social courtesies and gestures. 
I tend to avoid eye contact when conversing with others. 
I do not have an expressive and lively way of speaking. 











Lehman’s Quality of Life Brief Interview 
Item 1 2 3 4 5 6 7 
Select the item that best 
describes how you feel about 
your life in general.* 





Select the item that best 
describes where you have been 
living during the past month. 
































In a jail or 
prison 
On the streets or in an 
emergency shelter for 
the homeless. 
Select the item that best 
describes how you feel about the 
privacy you have where you 
live.* 





During the past month, did you 
work at a job for pay? 
No 1-5 days 6-10 days 11-15 
days 
16 or more days . 
During the past month, did you 
go to school? 
No 1-5 days 6-10 days 11-15 
days 
16 or more days . 
During the past month, did you No 1-5 days 6-10 days 11-15 16 or more days . 
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do volunteer work? days 
During the past month, did you 
keep house or take care of 
children? 
No 1-5 days 6-10 days 11-15 
days 
16 or more days . 
During the past month, did you 
go to a day program? 
No 1-5 days 6-10 days 11-15 
days 
16 or more days . 
Which of these activities did you 
consider your main activity 
during the past month? 
Working 


















Select the item that best 
describes how you feel about the 
amount of fun you have* 





Select the item that best 
describes how you feel about 
how you spend your time.* 





How often do you talk to a 
member of your family on the 
telephone? 





How often do you get together 
with a member of your family? 





Select the item that best 
describes how you feel about the 
way things are in general 
between you and your family.* 





How often do you spend time Daily Weekly Monthly Less than Not At . . 
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with a friend who does not live 
with you? 
Monthly All 
How often do you phone a 
friend who does not live with 
you? 





How often do you make plans 
ahead of time to do something 
with a friend? 





How often do you spend time 
with someone you consider 
more than a friend, like a 
boyfriend, girlfriend or you 
spouse? 





Select the item that best 
describes how you feel about the 
amount of friendship in your 
life.* 





Select the item next to the 
amount of money you had to 
spend on yourself during the 
past month, not counting money 






$51 to $100 More than $100 . . 
In the past month, did you have 
enough money for food? 
Yes No . . . . . 
In the past month, did you have 
enough money for clothes? 
Yes No . . . . . 
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In the past month, did you have 
enough money for housing? 
Yes No . . . . . 
In the past month, did you have 
enough money for 
transportation? 
Yes No . . . . . 
In the past month, did you have 
enough money for fun? 
Yes No . . . . . 
Select the item that best 
describes how you feel about 
how well off you are in 
financially.* 





In the past month were you the 
victim of any violent crime like 
assault, rape, mugging or 
robbery? 
Yes No . . . . . 
In the past month were you the 
victim of any non-violent crime 
like a theft, burglary or being 
cheated? 
Yes No . . . . . 
In the past month have you been 
arrested or picked up for any 
crime? 
Yes No . . . . . 
Select the item that best 
describes how you feel about the 
protection you have against 
being robbed or attacked.* 









Good Fair Poor . . 
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Select the item that best 
describes how you feel about 
your health in general.* 
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